Sing Huang Tan

Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers

Soo Chin Lee, Noriko Shimasaki, Joline S.J. Lim et al. · Clinical Cancer Research · 2020 · 67 citations · Full text

Life Sciences, Immunology, Oncology +17

Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: A randomised controlled trial to evaluate the effect of short message service (SMS) reminder

Eng Hooi Tan, Andrea Li Ann Wong, Chuan Chien Tan et al. · The Breast · 2020 · 39 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +13

Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia

Jia Li Low, Elaine Hsuen Lim, Lavina Bharwani et al. · Therapeutic Advances in Medical Oncology · 2022 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma.

Sing Huang Tan, Hiroshi Ida, Boon Cher Goh et al. · PubMed · 2007 · 20 citations

Medicine, Molecular Biology, Oncology +17

Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer

Kritika Yadav, Joline S.J. Lim, Joan Choo et al. · Breast Cancer Research and Treatment · 2021 · 16 citations · Full text

Medicine, Oncology, Pharmacology +15